Bromberg J, Issa S, Bukanina K, et al. Effect of Rituximab in Primary Central Nervous System Lymphoma – results of the Randomized Phase III HOVON 105/ALLG NHL 24 Study. ASH 59th Annual Meeting & Exhibition, abstract 582.
Odronextamab bij CD20-positieve B-celmaligniteiten: ELM-1
jul 2022 | Lymfoom